Market
Which institution will lead in dark microglia and Alzheimer's research publications by end of 2025?
2
Resolution / Starting Odds
Harvard University • 25%
Stanford University • 25%
University of California, San Francisco • 25%
Other • 25%
Publication databases such as PubMed or Web of Science
Story
Dark Microglia's Toxic Lipids Linked to Alzheimer's, Offering Potential Therapy
Dec 24, 2024, 07:47 PM
Researchers have identified a new mechanism involving 'dark microglia', a subset of brain immune cells, that may contribute to Alzheimer's disease. This discovery suggests that dark microglia produce and release toxic lipids, which can damage neurons. The study, published in the journal Neuron, indicates that inhibiting this mechanism in mice prevents neurodegeneration. The findings point to potential therapeutic targets for slowing down or even reversing Alzheimer's disease, according to the researchers involved.
View original story
Similar markets
No • 50%
Yes • 50%
No clear market leader • 25%
Other • 25%
LEQEMBI leads market • 25%
Competitor drug leads market • 25%
Xenon gas treatment • 25%
Other non-pharmacological interventions • 25%
Other pharmacological treatments • 25%
Aerobic exercise • 25%
Other • 25%
Oxford University • 25%
Harvard University • 25%
Johns Hopkins University • 25%
Cleveland Clinic • 25%
Johns Hopkins • 25%
Mayo Clinic • 25%
Other • 25%
Harvard University • 25%
University of California • 25%
Johns Hopkins University • 25%
Other • 25%
Beijing Institute of Technology • 25%
Other • 25%
Moscow State University • 25%
Technical University of Munich • 25%
Eisai and Biogen • 25%
Other companies • 25%
Eli Lilly • 25%
No dominant company • 25%
Genetic predisposition • 25%
Lifestyle factors • 25%
Socioeconomic status • 25%
Other factors • 25%
Yes • 50%
No • 50%
